Crescentis Capital Ltd Upgraded to Sell on Technical Improvements Despite Valuation Concerns

2 hours ago
share
Share Via
Crescentis Capital Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating upgraded from Strong Sell to Sell as of 22 May 2026. This change is primarily driven by a shift in technical indicators, although fundamental challenges and valuation concerns continue to weigh on the stock’s outlook.
Crescentis Capital Ltd Upgraded to Sell on Technical Improvements Despite Valuation Concerns

Quality Assessment: Weak Long-Term Fundamentals Persist

Despite the recent upgrade, Crescentis Capital’s quality metrics remain subdued. The company’s operating profits have exhibited a negative compound annual growth rate (CAGR) of -12.54%, signalling deteriorating core earnings over the long term. Return on Equity (ROE) stands at a meagre 0.3%, reflecting limited profitability relative to shareholder equity. This weak fundamental strength underpins the cautious stance on the stock despite short-term technical improvements.

Moreover, the company’s profitability has sharply declined over the past year, with net profits falling by 74.3%. This stark contraction contrasts with the stock’s price appreciation, highlighting a disconnect between market valuation and underlying earnings performance.

Valuation: Elevated Premium Amidst Weak Earnings

Crescentis Capital is currently trading at ₹120.50, representing a premium valuation with a Price to Book (P/B) ratio of 2.5. This is considered very expensive relative to its peers in the NBFC sector, especially given the company’s limited return on equity and declining profits. The stock’s valuation premium is further accentuated by its micro-cap status, which typically entails higher risk and volatility.

While the stock has outperformed the broader market indices, such as the Sensex and BSE500, over the past year with a return of 25.49% compared to the Sensex’s -6.84%, this performance is not supported by commensurate earnings growth. Investors should be wary of the stretched valuation in light of the company’s fundamental challenges.

This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!

  • - Precise target price set
  • - Weekly selection live
  • - Position check opportunity

Check Your Position →

Financial Trend: Mixed Signals from Recent Quarterly Performance

On the financial front, Crescentis Capital reported positive results for the quarter ending December 2025 (Q3 FY25-26). Profit Before Tax (PBT) excluding other income stood at ₹2.27 crores, marking a robust growth of 245.7% compared to the previous four-quarter average. Similarly, Profit After Tax (PAT) rose to ₹1.19 crores, an increase of 191.5% over the same period.

Cash and cash equivalents also reached a high of ₹27.69 crores in the half-year period, indicating improved liquidity. These short-term financial improvements provide some optimism but are tempered by the company’s weak long-term profit trajectory and operating profit decline.

Technical Analysis: Key Driver Behind Upgrade

The primary catalyst for the rating upgrade is the shift in technical indicators from a mildly bearish to a mildly bullish stance. The daily moving averages have turned bullish, signalling positive momentum in the stock price. On a monthly basis, the Moving Average Convergence Divergence (MACD) indicator remains bullish, while Bollinger Bands suggest a mildly bullish trend.

However, weekly MACD and KST (Know Sure Thing) indicators remain mildly bearish, reflecting some short-term caution. The Dow Theory analysis presents a mixed picture with weekly trends mildly bearish but monthly trends mildly bullish. Relative Strength Index (RSI) on both weekly and monthly charts shows no clear signal, indicating a neutral momentum.

Overall, the technical landscape has improved sufficiently to warrant an upgrade in the stock’s rating, despite the fundamental and valuation concerns.

Market Performance: Outperforming Despite Sector Challenges

Crescentis Capital’s stock has delivered impressive long-term returns, with a 10-year return of 1,677.29% compared to the Sensex’s 198.06%. Over five years, the stock has surged 604.68%, significantly outpacing the benchmark’s 49.22% gain. However, the three-year return is negative at -35.78%, reflecting recent volatility and sector headwinds.

In the short term, the stock has outperformed the Sensex across multiple periods: a 1-week return of 1.90% versus 0.24% for the Sensex, and a year-to-date return of 1.64% compared to the Sensex’s -11.51%. This market-beating performance is notable given the broader NBFC sector’s challenges and the company’s micro-cap status.

Crescentis Capital Ltd or something better? Our SwitchER feature analyzes this micro-cap Non Banking Financial Company (NBFC) stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Shareholding and Market Capitalisation

The majority shareholding in Crescentis Capital is held by promoters, which often provides stability in ownership and strategic direction. The company is classified as a micro-cap entity, which typically entails higher risk and lower liquidity compared to larger peers. This classification influences investor perception and contributes to the stock’s valuation dynamics.

Conclusion: Upgrade Reflects Technical Momentum but Fundamental Risks Remain

The upgrade of Crescentis Capital Ltd’s investment rating from Strong Sell to Sell is largely attributable to improved technical indicators signalling a shift towards mild bullishness. Daily moving averages and monthly MACD trends have strengthened, providing positive momentum for the stock price.

However, the company’s weak long-term fundamentals, including a negative operating profit CAGR of -12.54%, low ROE of 0.3%, and a significant decline in profits over the past year, continue to pose risks. The stock’s valuation remains expensive with a P/B ratio of 2.5, trading at a premium to peers despite these challenges.

Investors should weigh the short-term technical optimism against the backdrop of fundamental weaknesses and elevated valuation. While recent quarterly financial results show encouraging growth in profits and cash reserves, the overall outlook remains cautious. Market participants are advised to monitor both technical signals and fundamental developments closely before making investment decisions.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News